Candog, Atetchar S.

HRN: 27-08-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
CEFTRIAXONE 1G (VIAL)
05/08/2025
05/22/2025
IV
2g
OD
Open Fracture
Waiting Final Action 
05/16/2025
CO-AMOXICLAV 625MG (TAB)
05/16/2025
05/23/2025
ORAL
625mg
TID
S/P Debridement, ORIF, Left Fibula
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: